U. S. Securities and Exchange Commission
                         Washington, D. C.  20549


                                FORM 10-QSB


[X]  QUARTERLY REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES
     EXCHANGE ACT OF 1934

     For the quarterly period ended June 30, 2004

[ ]  TRANSITION REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES
     EXCHANGE ACT OF 1934

     For the transition period from                to
                                    --------------    ---------------

                     Commission File No.  000-31377

                          REFLECT SCIENTIFIC, INC.
                          ------------------------
          (Name of Small Business Issuer in its Charter)


             UTAH                                      87-0642556
             ----                                      ----------
  (State or Other Jurisdiction of              (I.R.S. Employer I.D. No.)
 incorporation or organization)

                          970 Terra Bella Avenue
                     Mountain View, California, 94043
                     --------------------------------
                  (Address of Principal Executive Offices)

            Issuer's Telephone Number:  (650) 960-0300


Indicate by check mark whether the Registrant (1) has filed all reports
required to be filed by Sections 13 or 15(d) of the Securities Exchange Act of
1934 during the preceding 12 months (or for such shorter period that the
Registrant was required to file such reports), and (2) has been
subject to such filing requirements for the past 90 days.

(1)  Yes  X     No                 (2)  Yes  X    No
         ---     ---                        ---     ---

<PAGE>
             APPLICABLE ONLY TO ISSUERS INVOLVED IN BANKRUPTCY
                PROCEEDINGS DURING THE PRECEDING FIVE YEARS

                              Not applicable.


                   APPLICABLE ONLY TO CORPORATE ISSUERS

Indicate the number of shares outstanding of each of the Registrant's classes
of common stock, as of the latest practicable date:

                               June 30, 2004

                                24,000,000
                                ----------

                      PART I - FINANCIAL INFORMATION


Item 1.   Financial Statements.
-------------------------------

          The Financial Statements of the Company required to be filed with
this 10-QSB Quarterly Report were prepared by management, and commence on the
following page, together with Related Notes.  In the opinion of management,
the Financial Statements fairly present the financial condition of the
Company.
<PAGE>
                    REFLECT SCIENTIFIC, INC.

                CONSOLIDATED FINANCIAL STATEMENTS

               June 30, 2004 and December 31, 2003
<PAGE>
<TABLE>
<CAPTION>
                    REFLECT SCIENTIFIC, INC.
                   Consolidated Balance Sheets

                              ASSETS

                                               June 30,          December 31,
                                                2004                2003
                                             (Unaudited)
<S>                                          <C>               <C>
CURRENT ASSETS

     Cash                                     $    57,080      $    99,924
     Accounts receivable, net                     369,411          232,464
     Inventory, net                               193,141          210,447
     Prepaid expenses                                 800              800
                                              -----------      -----------
          Total Current Assets                    620,432          543,635
                                              -----------      -----------
FIXED ASSETS (NET)                                 20,838           21,923
                                              -----------      -----------
OTHER ASSETS

     Deposits                                       5,350            5,350
     Capitalized loan costs, net                    5,775            6,125
                                              -----------      -----------
          Total Other Assets                       11,125           11,475
                                              -----------      -----------
          TOTAL ASSETS                        $   652,395      $   577,033
                                              ===========      ===========
</TABLE>
The accompanying notes are an integral part of these consolidated financial
statements.
                                2
<PAGE>
<TABLE>
<CAPTION>
                    REFLECT SCIENTIFIC, INC.
             Consolidated Balance Sheets (Continued)


               LIABILITIES AND SHAREHOLDERS' EQUITY

                                               June 30,        December 31,
                                                2004                2003
                                             (Unaudited)
<S>                                          <C>               <C>
CURRENT LIABILITIES

     Accounts payable                         $    179,426     $    199,374
     Accrued expenses                               19,169           15,180
     Income taxes payable                           13,200                -
                                              ------------     ------------
          Total Current Liabilities                211,795          214,554
                                              ------------     ------------
NON-CURRENT LIABILITIES

     Long term line of credit                      268,986          269,011
                                              ------------     ------------
          Total Non-Current Liabilities            268,986          269,011
                                              ------------     ------------
          Total Liabilities                        480,781          483,565
                                              ------------     ------------
COMMITMENTS AND CONTINGENCIES

SHAREHOLDERS' EQUITY

     Common stock, $0.01 par value, authorized
     50,000,000 shares; 24,000,000 shares
     issued and outstanding                        240,000          240,000
     Additional paid-in capital (deficit)         (188,319)        (210,841)
     Retained earnings                             119,933           64,309
                                             -------------     ------------
          Total Shareholders' Equity               171,614           93,468
                                             -------------     ------------
          TOTAL LIABILITIES AND SHAREHOLDERS'
          EQUITY                             $     652,395     $    577,033
                                             =============     ============
</TABLE>
The accompanying notes are an integral part of these consolidated financial
statements.
                                3
<PAGE>
<TABLE>
<CAPTION>
                    REFLECT SCIENTIFIC, INC.
              Consolidated Statements of Operations
                           (Unaudited)


                          For the Three Months Ended  For the Six Months Ended
                                   June 30,                   June 30,
                           2004                2003     2004            2003
<S>                           <C>           <C>         <C>         <C>
REVENUES                      $ 581,656     $ 464,983   $ 1,081,707 $ 958,338

COST OF GOODS SOLD              332,912       305,812       644,035   581,886
                               --------     ---------   ----------- ---------
GROSS PROFIT                    248,744       159,171       437,672   376,452
                               --------     ---------   ----------- ---------
OPERATING EXPENSES

     Salaries and wages          86,848        74,852       176,182   151,774
     Payroll taxes                6,639         6,275        15,431    13,258
     Rent expense                18,999        24,938        38,058    37,480
     General and
      administrative expense     67,638        17,552       138,168    82,196
                               --------     ---------   ----------- ---------
   Total Operating Expenses     180,124       123,619       367,839   284,708
                               --------     ---------   ----------- ---------
OPERATING INCOME                 68,620        35,552        69,833    91,744
                               --------     ---------   ----------- ---------
OTHER INCOME (EXPENSE)

     Sundry income                5,000        30,000         5,000    30,000
     Miscellaneous income
      (expense)                       -        16,283          (301)   16,015
     Interest expense            (2,851)       (3,435)       (5,707)   (8,068)
                               --------     ---------   ----------- ---------
          Total Other Income
          (Expense)               2,149        42,848        (1,008)   37,947
                               --------     ---------   ----------- ---------
NET INCOME BEFORE INCOME TAX     70,769        78,400        68,825   129,691
                               --------     ---------   ----------- ---------
INCOME TAX EXPENSE               13,200             -        13,200         -

NET INCOME                     $ 57,569     $  78,400   $    55,625 $ 129,691
                               ========     =========   =========== =========
EARNINGS PER SHARE             $   0.00     $    0.00   $      0.00 $    0.01
                               ========     =========   =========== =========
WEIGHTED AVERAGE NUMBER OF
SHARES OUTSTANDING           24,000,000    22,914,949    24,000,000 22,914,949
                             ==========    ==========   =========== ==========
</TABLE>
The accompanying notes are an integral part of these consolidated financial
statements.
                                4
<PAGE>
<TABLE>
<CAPTION>
                    REFLECT SCIENTIFIC, INC.
              Consolidated Statements of Cash Flows
                           (Unaudited)

                                                 For the
                                            Six Months Ended
                                                 June 30,
                                          2004                2003
<S>                                      <C>           <C>
CASH FLOWS FROM OPERATING ACTIVITIES

     Net income                           $    55,625     $   129,693
     Adjustments to reconcile net income
      to net cash provided by operating
      activities:
          Depreciation                            350           1,184
          Amortization of capitalized loan
          costs                                 1,085             420
     Changes in operating assets and
     liabilities:
          (Increase) in accounts
          receivable                         (136,947)        (46,685)
          Decrease in inventory                17,305          39,454
          Decrease in prepaid expenses              -           6,124
          Increase (decrease) in accounts
          payable and accrued expenses        (15,959)          9,531
          Increase in income taxes payable     13,200               -
                                           ----------     -----------
               Net Cash Used by Operating
               Activities                     (65,341)        139,721

CASH FLOWS FROM INVESTING ACTIVITIES

CASH FLOWS FROM FINANCING ACTIVITIES

     Payments on short term lines of credit         -               -
     Change in long term line of credit           (25)              -
     Contributed capital                       22,522          (1,579)
     Distribution to shareholder                    -        (101,000)
                                           ----------     -----------
               Net Cash (Used) Provided by
               Financing Activities            22,497        (102,579)
                                           ----------     -----------
NET DECREASE IN CASH                          (42,844)         37,142

CASH AT BEGINNING OF PERIOD                    99,924         115,644
                                           ----------     -----------
CASH AT END OF PERIOD                      $   57,080     $   152,786
                                           ==========     ===========

NON-CASH INVESTING AND FINANCING ACTIVITIES:

     Cash Paid For:

          Interest                         $    4,729     $     7,068
          Income taxes                     $        -     $         -

</TABLE>
The accompanying notes are an integral part of these consolidated financial
statements.
                                5
<PAGE>
                    REFLECT SCIENTIFIC, INC.
          Notes to the Consolidated Financial Statements
               June 30, 2004 and December 31, 2003


NOTE 1 -  BASIS OF FINANCIAL STATEMENT PRESENTATION

     The accompanying unaudited condensed financial statements have been
     prepared by the Company pursuant to accounting principles generally
     accepted in the United States of America. Certain information and
     footnote disclosures normally included in financial statements prepared
     in accordance with accounting principles generally accepted in the
     United States of America have been condensed or omitted in accordance
     with such rules and regulations.  The information furnished in the
     interim condensed financial statements include normal recurring
     adjustments and reflects all adjustments, which, in the opinion of
     management, are necessary for a fair presentation of such financial
     statements.  Although management believes the disclosures and
     information presented are adequate to make the information not
     misleading, it is suggested that these interim condensed financial
     statements be read in conjunction with the Company's most recent audited
     financial statements and notes thereto included in its December 31, 2003
     financial statements.  Operating results for the six months ended June
     30, 2004 are not necessarily indicative of the results that may be
     expected for the year ending December 31, 2004.

NOTE 2 - ACQUISITION OF REFLECT SCIENTIFIC

     On December 30, 2003, pursuant to an agreement and plan of
     reorganization, the Company completed a reverse merger with the
     shareholder of Reflect Scientific, Inc. in which it acquired 100% of
     Reflect Scientific, Inc., a California Company in exchange for 22,914,949
     common shares of the Company.  The terms of the acquisition are detailed
     in an 8-K filing dated December 31, 2003.  Under the terms of the
     agreement, the President of Reflect Scientific, Inc. became the President
     of the Company and was elected to the Board of Directors, the acquisition
     was accounted for as a recapitalization of Reflect Scientific, Inc.
     because the members of Reflect Scientific, Inc. controlled the Company
     after the acquisition. Reflect Scientific, Inc. was treated as the
     acquiring entity for accounting purposes and Cole, Inc. was the surviving
     entity for legal purposes.  There was no adjustment to the carrying
     values of the assets or liabilities of Reflect Scientific, Inc. and no
     goodwill was recorded.

                                6
<PAGE>

Item 2.   Management's Discussion and Analysis or Plan of Operation.
--------------------------------------------------------------------

Results of Operations.
----------------------

          Our revenues increased during the quarter ended June 30, 2004, to
$581,656 from $464,983 for the quarter ended June 30, 2003, primarily as
a result of a general improvement in sales across several new product lines
and improving market conditions.

          Our cost of goods increased in the period ending June 30, 2004,
as compared to June 30, 2003, to $332,912 from $305,812. The difference
was partly as a result of an increase in sales, increased raw material costs
and increased labor costs.

          General and administrative expenses increased to $67,638 during the
quarter ended June 30, 2004, from $17,552 during the quarter ended June 30,
2003. This increase was due to the addition of one full-time employee,
increased payroll and increased operational expenses, like legal and
accounting fees.

     Liquidity and Capital Resources.
     --------------------------------

          Our cash resources at June 30, 2004, were $57,080, with accounts
receivable of $369,411.  We have relied on revenues and lines of credit for
our cash resources.  At June 30, 2004, we had utilized $268,986 of our
$400,000 line of credit.  These funds should be adequate for the next 12
months for continuing operations; however, plans for expansion will require
additional capital of between $500,000 and $750,000.

     Forward-Looking Statements.
     ---------------------------

         The Private Securities Litigation Reform Act of 1995 (the "Act")
provides a safe harbor for forward-looking statements made by or on behalf of
our Company.  Our Company and its representatives may from time to time make
written or oral statements that are "forward- looking," including statements
contained in this Quarterly Report and other filings with the Securities and
Exchange Commission and in reports to our Company's stockholders. Management
believes that all statements that express expectations and projections with
respect to future matters, as well as from developments beyond our Company's
control including changes in global economic conditions are forward-looking
statements within the meaning of the Act. These statements are made on the
basis of management's views and assumptions, as of the time the statements are
made, regarding future events and business performance. There can be no
assurance, however, that management's expectations will necessarily come to
pass.  Factors that may affect forward- looking statements include a wide
range of factors that could materially affect future developments and
performance, including the following:

         Changes in Company-wide strategies, which may result in changes in
the types or mix of businesses in which our Company is involved or chooses to
invest; changes in U.S., global or regional economic conditions, changes in
U.S. and global financial and equity markets, including significant interest
rate fluctuations, which may impede our Company's access to, or increase the
cost of, external financing for our operations and investments; increased
competitive pressures, both domestically and internationally, legal and
regulatory developments, such as regulatory actions affecting environmental
activities, the imposition by foreign countries of trade restrictions and
changes in international tax laws or currency controls; adverse weather
conditions or natural disasters, such as hurricanes and earthquakes, labor
disputes, which may lead to increased costs or disruption of operations.

         This list of factors that may affect future performance and the
accuracy of forward-looking statements is illustrative, but by no means
exhaustive.  Accordingly, all forward-looking statements should be evaluated
with the understanding of their inherent uncertainty.

Item 3. Controls and Procedures.
----------------------------------

     As of the end of the period covered by this Quarterly Report, we carried
out an evaluation, under the supervision and with the participation of our
President and Treasurer, of the effectiveness of our disclosure controls and
procedures.  Based on this evaluation, our President and Treasurer concluded
that our disclosure controls and procedures are effective in timely alerting
them to material information required to be included in our periodic
Securities and Exchange Commission reports.  It should be noted that the
design of any system of controls is based in part upon certain assumptions
about the likelihood of future events, and there can be no assurance that any
design will succeed in achieving its stated goals under all potential future
conditions, regardless of how remote.  In addition, we reviewed our internal
controls over financial reporting, and there have been no changes in our
internal controls or in other factors in the last fiscal quarter that has
materially affected or is reasonably likely to materially affect our internal
control over financial reporting.

                        PART II - OTHER INFORMATION

Item 1.   Legal Proceedings.
----------------------------

          None; not applicable.

Item 2.   Changes in Securities and Small Business Issuer Purchases of Equity
Securities.
-----------

          None; not applicable.

Item 3.   Defaults Upon Senior Securities.
------------------------------------------

          None; not applicable.

Item 4.   Submission of Matters to a Vote of Security Holders.
--------------------------------------------------------------

          None; not applicable.

Item 5.   Other Information.
----------------------------

          None; not applicable.

Item 6.   Exhibits and Reports on Form 8-K.
-------------------------------------------

          (a)  Exhibits.

               31.1   302 Certification of Kim Boyce

               31.2   302 Certification of Pamela Boyce

               32     906 Certification.

          (b)  Reports on Form 8-K.

               None.


                               SIGNATURES

          Pursuant to the requirements of the Securities Exchange Act of 1934,
the Registrant has duly caused this Report to be signed on its behalf by the
undersigned thereunto duly authorized.

                                          REFLECT SCIENTIFIC, INC.

Date: 8/16/2004                           /s/Kim Boyce
                                          ------------------------------------
                                          Kim Boyce, President


Date: 8/16/2004                          /s/Pamela Boyce
                                          ------------------------------------
                                          Pamela Boyce, Secretary
<PAGE>